Duchesnay Inc. v. Actavis Inc.
1:14-cv-00912
Overview
Parties
Defendant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
10 Attorneys ListedADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN, (302) 888-6800
Actavis Pharma Inc. Operating Company
Represented By
2 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Plaintiff
Duchesnay USA Inc. Operating Company
Represented By
5 Attorneys ListedPolsinelli PC
222 Delaware Avenue, Suite 1101, Wilmington, DE 19801
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Duchesnay Inc. Operating Company
Represented By
11 Attorneys ListedPolsinelli PC
222 Delaware Avenue, Suite 1101, Wilmington, DE 19801
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Counter Claimant
Actavis Laboratories FL Inc. Operating Company
Represented By
5 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Defendant
Actavis Inc. Operating Company
Represented By
7 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇨🇦 Canada | CA 002350195 A | Canada Counterpart | View Official Patent → |
| 🇨🇦 Canada | CA 2350195 C | Canada Counterpart | View Official Patent → |
| 🇩🇪 Germany | DE 10196426 T | Germany Counterpart | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 1,951,259 A | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 1,397,133 B1 | European Counterpart (EP) | View Official Patent → |
| 🇩🇪 Germany | DE 60114475 T | Germany Counterpart | View Official Patent → |
| 🇺🇸 United States | US 6,340,695 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇰🇷 South Korea | KR 100527985 B1 | South Korea Counterpart | View Official Patent → |
| 🇨🇳 China | CN 1229112 C | China Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2003000263 A1 | PCT World Application | View Official Patent → |
| 🇯🇵 Japan | JP 2003506908 A | Japan Counterpart | View Official Patent → |
| 🇯🇵 Japan | JP 4242763 B2 | Japan Counterpart | View Official Patent → |
| 🇬🇧 United Kingdom | GB 0213990 A | United Kingdom Counterpart | View Official Patent → |
| 🇬🇧 United Kingdom | GB 2383751 C | United Kingdom Counterpart | View Official Patent → |
| 🇫🇷 France | FR 0207643 A | France Counterpart | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6340695
Rapid onset formulation
|
Filed: 2001-06-21
Issued: 2002-01-22
|
Expired (Term Ended)
Expires: 2021-06-21
|
|
|
US7560122
Pharmaceutical dosage form bearing pregnancy-friendly indicia
|
Filed: 2003-07-01
Issued: 2009-07-14
|
Expired (Term Ended)
+576d PTA
Expires: 2025-01-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
45
Dispositive
0
Granted
0
Denied
0
Pending / Review
27
Motions by Category
Key Dispositive Motions & Rulings